Showing results (41-50 of 291) with videos related to
Sort By:
Pageof 30
Trends in Pharmacological Sciences|May 8, 2001
Therapeutic modulation of transcription factor activityJ G Emery, E H Ohlstein, M JayeAmerican Journal of Hypertension|March 21, 1998
Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failureR R Ruffolo, G Z Feuerstein, E H OhlsteinTrends in Pharmacological Sciences|May 1, 1996
California dreamin' 'bout endothelin: emerging new therapeuticsT D Warner, J D Elliott, E H OhlsteinThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526E H Ohlstein, B Zabko-Potapovich, B A BerkowitzThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dogG A Kopia, E H Ohlstein, R R RuffoloEuropean Journal of Pharmacology|October 20, 1992
Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responsesS A Douglas, J D Elliott, E H OhlsteinAmerican Heart Journal|September 1, 1999
Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical dataD P Brooks, E H Ohlstein, R R RuffoloDNA and Cell Biology|April 1, 1996
Isolation and characterization of BART-1: A novel balloon angioplasty responsive transcript in rat carotid arteriesM V Autieri, M B Prystowsky, E H OhlsteinJournal of Cardiovascular Pharmacology|February 1, 1993
Carvedilol inhibits vascular smooth muscle cell proliferationC P Sung, A J Arleth, E H OhlsteinThe Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Relationship between LTD4-induced endothelium-dependent vasomotor relaxation and cGMPR J Secrest, E H Ohlstein, B M ChapnickPageof 30